Attached corrigendum to Unadudited Financail Results for the quarter ended December 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Raaj Medisafe India has filed a corrigendum to its Q3 FY26 unaudited financial results to correct a typographical error: the date of the board meeting was wrongly stated as 11th December 2025 instead of the correct date of 11th February 2026. The company has confirmed that there are no other changes to the results or the limited review report. Underlying numbers show strong growth — Q3 revenue from operations rose to Rs. 2,070.68 lakhs (vs Rs. 1,458.98 lakhs in Q3 FY25, ~42% YoY), while net profit jumped to Rs. 189.42 lakhs (vs Rs. 102.52 lakhs, ~85% YoY). Nine-month revenue stood at Rs. 5,493.78 lakhs and net profit at Rs. 461.65 lakhs, with EPS of Rs. 3.51.
This is a minor administrative correction with no impact on actual financials — shareholders should treat the originally disclosed numbers as final. The strong underlying revenue and profit growth remains intact and is a positive signal for the stock.